Robert Sidlow MD MBA
Interim Chief, General Medicine Attending and Clinical Professor, Memorial Sloan Kettering Cancer Center
Request Appointment
300 East 66th StreetNew York, NY 10065
Overview of Dr. Sidlow
I am a board-certified internal medicine specialist whose interest is in the care of cancer patients: co-management of complex patients undergoing chemotherapy, radiotherapy, and surgery; long term management of cancer survivors; management of patients at high risk for cancer (i.e. carriers of germline mutations; post-cancer treatment patients); preventive cardiology in patients with clonal hematopoesis.
Education & Training
City of HopeCancer Genomic Risk, 2020 - 2021
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1995 - 1998
Columbia University Vagelos College of Physicians and SurgeonsClass of 1995
Certifications & Licensure
NJ State Medical License 2017 - 2027
CT State Medical License 2023 - 2026
NY State Medical License 1996 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hospice and Palliative Medicine
City of HopeCancer Genomics Risk Assessment
Awards, Honors, & Recognition
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Publications & Presentations
PubMed
- 32 citationsThe experience of financial toxicity among advanced melanoma patients treated with immunotherapyBridgette Thom, Maha Mamoor, Jessica A. Lavery, Shrujal S. Baxi, Niloufer Khan
Journal of Psychosocial Oncology. 2021-03-04 - 8 citationsThe Hospitalist Model and Oncology: Oncologist Opinions About Inpatient Cancer Care DeliveryKathleen R. Atlas, Barbara Egan, Caroline J. Novak, Robert Sidlow
The Oncologist. 2020-12-01 - 30 citationsThe Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk Factor.Robert Sidlow, Amy E. Lin, Dipti Gupta, Kelly L. Bolton, David P. Steensma
JAMA Cardiology. 2020-05-27
Journal Articles
- The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk FactorRobert Sidlow, Amy E Lin, David P Steensma, Benjamin L Ebert, JAMA Cardiology
Authored Content
- The Clinical Challenge of Clonal Hematopoiesis, a Newly Recognized Cardiovascular Risk FactorMay 2020
Press Mentions
Hereditary Cancers Aren’t Just a Women’s Problem. Jewish Men Need to Take Precautions TooNovember 28th, 2022
Professional Memberships
- Fellow
Other Languages
- Spanish
Insurance Accepted
- Aetna Choice POS II
BCBS Blue Card PPO
BCBS New Mexico PPO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
Great West PPOHIP of New York - Select PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Presbyterian Commercial
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
